QLS1209

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS1209, covering 2025-03-12 to 2025-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors [Phase 1]